🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a masked, multi-center, daily wear, monthly replacement, bila...
Status
Completed
Location
Eric White, O.D., Inc.
Start Date
2015-09-21
Trial ID
NCT02555722
Treatments Being Tested
The purpose of this study is to gather long-term performance and safety dat...
Status
Withdrawn
Location
Contact Alcon Call Center for Trial Locations
Start Date
2025-01
Trial ID
NCT06493383
Treatments Being Tested
The purpose of this study is to assess long term performance and safety of ...
Status
Completed
Location
Tallahassee Eye Center
Start Date
2023-03-25
Trial ID
NCT05790928
Treatments Being Tested
The two-year prospective study aims at investigating frequently replacement...
Status
Unknown
Location
School of Optometry, The Hong Kong Polytechnic University
Start Date
2020-07-07
Trial ID
NCT04293328
Treatments Being Tested
The purpose of this study is to evaluate the thickness of the pre-lens tear...
Status
Completed
Location
Multiple Locations
Start Date
2014-11
Trial ID
NCT02293538
Treatments Being Tested
To evaluate the wear experience of current monthly replacement contact lens...
Status
Completed
Location
The Ohio State University College of Optometry
Start Date
2021-05-28
Trial ID
NCT05096156
Treatments Being Tested
The two-year prospective study aims at investigating the benefits of freque...
Status
Unknown
Location
School of Optometry, The Hong Kong Polytechnic University
Start Date
2020-03-11
Trial ID
NCT04295707
Treatments Being Tested
Determine if Total30 for Astigmatism contact lenses (CLs) provide a comfort...
Status
Completed
Location
Kannarr Eye Care
Start Date
2023-10-15
Trial ID
NCT06052046
Treatments Being Tested
The aim of the study is to evaluate if the performance of Invigor A is subs...
Status
Completed
Location
Mark Nakano. O.D
Start Date
2018-10-10
Trial ID
NCT03722784
Treatments Being Tested